Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
10.1186/s12885-014-1001-3
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181461 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-181461 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1814612024-03-27T08:13:53Z Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma Xu, Y Peng, Z Li, Z Lu, M Gao, J Li, Y Li, Y Shen, L MICROBIOLOGY AND IMMUNOLOGY antineoplastic agent cisplatin epidermal growth factor receptor kinase inhibitor irinotecan nimotuzumab paclitaxel scatter factor receptor antineoplastic agent EGFR protein, human epidermal growth factor receptor MET protein, human protein kinase inhibitor scatter factor receptor adult advanced cancer Article cancer center cancer combination chemotherapy cancer localization cancer patient cancer prognosis cancer survival clinical feature controlled study esophageal squamous cell carcinoma female histopathology human human tissue immunohistochemistry major clinical study male overall survival phase 2 clinical trial (topic) prediction protein expression retrospective study sex university hospital antagonists and inhibitors Carcinoma, Squamous Cell Esophageal Neoplasms metabolism pathology prognosis survival analysis upregulation Antineoplastic Agents Carcinoma, Squamous Cell Esophageal Neoplasms Female Humans Male Prognosis Protein Kinase Inhibitors Proto-Oncogene Proteins c-met Receptor, Epidermal Growth Factor Survival Analysis Up-Regulation 10.1186/s12885-014-1001-3 BMC Cancer 15 1 6 2020-10-27T10:59:49Z 2020-10-27T10:59:49Z 2015 Article Xu, Y, Peng, Z, Li, Z, Lu, M, Gao, J, Li, Y, Li, Y, Shen, L (2015). Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma. BMC Cancer 15 (1) : 6. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-014-1001-3 14712407 https://scholarbank.nus.edu.sg/handle/10635/181461 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
antineoplastic agent cisplatin epidermal growth factor receptor kinase inhibitor irinotecan nimotuzumab paclitaxel scatter factor receptor antineoplastic agent EGFR protein, human epidermal growth factor receptor MET protein, human protein kinase inhibitor scatter factor receptor adult advanced cancer Article cancer center cancer combination chemotherapy cancer localization cancer patient cancer prognosis cancer survival clinical feature controlled study esophageal squamous cell carcinoma female histopathology human human tissue immunohistochemistry major clinical study male overall survival phase 2 clinical trial (topic) prediction protein expression retrospective study sex university hospital antagonists and inhibitors Carcinoma, Squamous Cell Esophageal Neoplasms metabolism pathology prognosis survival analysis upregulation Antineoplastic Agents Carcinoma, Squamous Cell Esophageal Neoplasms Female Humans Male Prognosis Protein Kinase Inhibitors Proto-Oncogene Proteins c-met Receptor, Epidermal Growth Factor Survival Analysis Up-Regulation |
| spellingShingle |
antineoplastic agent cisplatin epidermal growth factor receptor kinase inhibitor irinotecan nimotuzumab paclitaxel scatter factor receptor antineoplastic agent EGFR protein, human epidermal growth factor receptor MET protein, human protein kinase inhibitor scatter factor receptor adult advanced cancer Article cancer center cancer combination chemotherapy cancer localization cancer patient cancer prognosis cancer survival clinical feature controlled study esophageal squamous cell carcinoma female histopathology human human tissue immunohistochemistry major clinical study male overall survival phase 2 clinical trial (topic) prediction protein expression retrospective study sex university hospital antagonists and inhibitors Carcinoma, Squamous Cell Esophageal Neoplasms metabolism pathology prognosis survival analysis upregulation Antineoplastic Agents Carcinoma, Squamous Cell Esophageal Neoplasms Female Humans Male Prognosis Protein Kinase Inhibitors Proto-Oncogene Proteins c-met Receptor, Epidermal Growth Factor Survival Analysis Up-Regulation Xu, Y Peng, Z Li, Z Lu, M Gao, J Li, Y Li, Y Shen, L Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma |
| description |
10.1186/s12885-014-1001-3 |
| author2 |
MICROBIOLOGY AND IMMUNOLOGY |
| author_facet |
MICROBIOLOGY AND IMMUNOLOGY Xu, Y Peng, Z Li, Z Lu, M Gao, J Li, Y Li, Y Shen, L |
| format |
Article |
| author |
Xu, Y Peng, Z Li, Z Lu, M Gao, J Li, Y Li, Y Shen, L |
| author_sort |
Xu, Y |
| title |
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma |
| title_short |
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma |
| title_full |
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma |
| title_fullStr |
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma |
| title_full_unstemmed |
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma |
| title_sort |
expression and clinical significance of c-met in advanced esophageal squamous cell carcinoma |
| publishDate |
2020 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/181461 |
| _version_ |
1795301317888966656 |